Annual Accounts Receivable
$15.00 M
+$15.00 M+100.00%
December 31, 2023
Summary
- As of February 22, 2025, KYMR annual accounts receivable is $15.00 million, with the most recent change of +$15.00 million (+100.00%) on December 31, 2023.
- During the last 3 years, KYMR annual accounts receivable has risen by +$14.42 million (+2499.65%).
- KYMR annual accounts receivable is now at all-time high.
Performance
KYMR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 22, 2025, KYMR quarterly accounts receivable is $0.00, unchanged on September 30, 2024.
- Over the past year, KYMR quarterly accounts receivable has dropped by -$15.00 million (-100.00%).
- KYMR quarterly accounts receivable is now -100.00% below its all-time high of $15.00 million, reached on December 31, 2023.
Performance
KYMR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
KYMR Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | +2499.7% | -100.0% |
| 5 y5 years | - | -100.0% |
KYMR Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -100.0% | at low |
| 5 y | 5-year | at high | -100.0% | -100.0% | at low |
| alltime | all time | at high | -100.0% | -100.0% | at low |
Kymera Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $15.00 M(>+9900.0%) | $15.00 M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $856.00 K(+48.4%) |
| Dec 2020 | $577.00 K(>+9900.0%) | $577.00 K(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Kymera Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Kymera Therapeutics?
- What is Kymera Therapeutics annual accounts receivable year-on-year change?
- What is Kymera Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly accounts receivable year-on-year change?
What is Kymera Therapeutics annual accounts receivable?
The current annual accounts receivable of KYMR is $15.00 M
What is the all time high annual accounts receivable for Kymera Therapeutics?
Kymera Therapeutics all-time high annual accounts receivable is $15.00 M
What is Kymera Therapeutics annual accounts receivable year-on-year change?
Over the past year, KYMR annual accounts receivable has changed by +$15.00 M (+100.00%)
What is Kymera Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of KYMR is $0.00
What is the all time high quarterly accounts receivable for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly accounts receivable is $15.00 M
What is Kymera Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, KYMR quarterly accounts receivable has changed by -$15.00 M (-100.00%)